Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 240,000 | reported | 02 Jan 2026 | tx 42+2,328,478−1,154,870 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 240,000 | 0.00 USD | deriv |
| 12 Nov 2025 | SALE | ARS Pharmaceuticals, Inc. | 136,380 | 8.86 USD | |
| 12 Nov 2025 | SALE | ARS Pharmaceuticals, Inc. | 30,000 | 8.91 USD | anomaly |
| 12 Nov 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 30,000 | 0.84 USD | |
| 12 Nov 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 274,100 | 0.00 USD | deriv |
| 13 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 27,272 | 12.06 USD | |
| 13 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 27,272 | 1.44 USD | |
| 12 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 117,333 | 0.84 USD | |
| 12 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 117,333 | 12.27 USD | anomaly |
| 12 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 117,333 | 0.00 USD | deriv |
| 13 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 27,272 | 0.00 USD | deriv |
| 10 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 0.84 USD | |
| 10 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.15 USD | |
| 10 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 0.84 USD | |
| 05 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 49,640 | 14.13 USD | |
| 05 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 49,640 | 0.84 USD | |
| 04 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 45,000 | 13.95 USD | |
| 06 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 14.23 USD | |
| 04 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 45,000 | 0.84 USD | |
| 04 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 45,000 | 0.00 USD | deriv |
| 05 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 49,640 | 0.00 USD | deriv |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 03 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 45,000 | 13.19 USD |